ArticleOncotarget2017
EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling.
Meng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it
ArticleOncotarget2017
Meng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.